The role of sentinel lymph nodes in malignant melanoma

Surgical Clinics of North America

Volumn 80, Issue 6, 2000, Pages 1741-1757

  Leong, Stanley P L ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON;

CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; DIAGNOSTIC ACCURACY; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MELANOMA; PEROPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; SENTINEL LYMPH NODE;

EID: 0034528427     PISSN: 00396109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-6109(05)70258-9     Document Type: Article

References (65)

1. Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma
2. Gamma-probe-guided localization of lymph nodes
3. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger
4. The role of elective lymph node dissection in melanoma: Rationale, results and controversies
5. A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II)
6. Lymphoscintigraphy in malignant melanoma
7. Intraoperative lymphatic mapping for early-stage melanoma of the head and neck
8. An approach for the treatment of penile carcinomal
9. Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes
10. Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases
11. A multivariate analysis of clinical and pathologic variables in prognosis after resection of large bowel cancer
12. Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma
13. Society of Surgical Oncology practice guidelines. Melanoma surgical practice guidelines
14. Results of treatment of 269 patients with primary cutaneous melanoma: A five-year prospective study
15. Sentinel lymph node biopsy in malignant melanoma: The standard of care?
16. Radiopharmaceuticals for lymphoscintigraphy: Including dosimetry and radiation considerations
17. The determination of lymph shed by colloidal gold scanning patients with malignant melanoma: A preliminary study
18. Multi-institutional melanoma lymphatic mapping experience: The prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients
19. The role of selective lymphadenectomy in the management of patients with malignant melanoma
20. The use of intraoperative radiolymphoscintigraphy for sentinel node biopsy in patients with malignant melanoma
21. NCCN melanoma practice guidelines
22. Radioguided surgery for the ultrastaging of the patient with melanoma
23. Localizing the sentinel node in cutaneous melanoma: Gamma probe detection versus blue dye
24. Surgical treatment of malignant melanoma
25. The technique of sentinel node biopsy
26. Interferon alpha-2b adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST 1684
27. Minimal-access surgery for staging of malignant melanoma
28. Defining lymphatic drainage patterns with cutaneous lymphoscintigraphy
29. Clinicopathological correlation in a series of 117 malignant melanomas of the skin of adults
30. Clinical significance of melanoma micrometastasis to sentinel lymph nodes and other high risk factors
31. Adverse reactions to isosulfan blue during selective sentinel lymph node dissection in melanoma
32. Discordancy between clinical predictions versus lymphoscintigraphic and intraoperative mapping of sentinel lymph node drainage of primary melanoma
33. Optimal selective sentinel lymph node dissection in primary malignant melanoma
34. Intraoperative identification of sentinel lymph node in patients with malignant melanoma
35. Sunbelt Melanoma Trials: Sensitivity and specificity of reverse transcriptase polymerase chain reaction (RT-PCR) markers for sentinel lymph nodes (SLN)
36. Prognosis in malignant melanoma
37. Technetium-99m sulfur-colloid cutaneous lymphoscintigraphy in the management of truncal melanoma
38. Current status of intraoperative lymphatic mapping and sentinel lymphadenectomy for melanoma: Is it standard of care?
39. Management of early stage melanoma by intraoperative lymphatic mapping and selective lymphadenectomy
40. Technical details of intraoperative lymphatic mapping for early stage melanoma
41. Management and survival of female breast cancer: Results of a national survey by the American College of Surgeons
42. The relationship of survival to staging and grading of colorectal carcinoma: A prospective study of 503 cases
43. Sentinel node biopsy in melanoma patients: Dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital dye guidance
44. The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanoma
45. Accurate nodal staging of malignant melanoma
46. Changing standards of surgical care for melanoma patients
47. The orderly progression of melanoma nodal metastases
48. Sentinel lymph-node biopsy in melanoma: Is less surgery better?
49. Pathological evaluation of the regional lymph nodes in malignant melanoma
50. Prognosis of patients with pathologic stage II cutaneous malignant melanoma
51. Selective lymphadenectomy: Emerging role for lymphatic mapping and sentinel node biopsy in the management of early stage melanoma
52. A prospective randomized study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma: Preliminary results
53. Lymphoscintigraphy in malignant melanoma: 99mTc antimony sulfur colloid
54. Sentinel lymph node status as one indicator of the presence of metastatic melanoma in regional lymph nodes
55. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes
56. Lymphoscintigraphy in high risk melanoma of the trunk: Predicting draining node groups, defining lymphatic channels and locating the sentinel node
57. Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy
58. Inefficacy of immediate node dissection in stage I melanoma of the limbs
59. Radionuclide lymphoscintigraphy with technetium 99m antimony sulfide colloid to identify lymphatic drainage of cutaneous melanoma at ambiguous sites in the head and neck and trunk
60. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma
61. Sentinel lymph node biopsy in melanoma of the head and neck
62. Timing of sentinel lymph node mapping after lymphoscintigraphy
63. Lymphatic drainage of skin to a sentinel lymph node in a feline model